Listed

CVS HEALTH Corp: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on May 2, 2014 and accepted by EDGAR at May 2, 2014, 17:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-01-01 to 2014-03-31$32.69bnus-gaap:Revenues
Cost of revenue3 months2014-01-01 to 2014-03-31$26.75bnus-gaap:CostOfRevenue
Gross profit3 months2014-01-01 to 2014-03-31$5.94bnus-gaap:GrossProfit
Operating income3 months2014-01-01 to 2014-03-31$2.02bnus-gaap:OperatingIncomeLoss
Interest expense3 months2014-01-01 to 2014-03-31$161.0mus-gaap:InterestExpense
Income tax3 months2014-01-01 to 2014-03-31$737.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-01-01 to 2014-03-31$1.13bnus-gaap:ProfitLoss
Diluted EPS3 months2014-01-01 to 2014-03-31$0.95us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-01-01 to 2014-03-31$0.96us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-01-01 to 2014-03-311,190,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2014-01-01 to 2014-03-31$2.17bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2014-01-01 to 2014-03-31$388.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2014-01-01 to 2014-03-31$325.0mus-gaap:PaymentsOfDividends
Share repurchases3 months2014-01-01 to 2014-03-31$801.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-03-31$2.77bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-03-31$24.46bnus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$72.82bnus-gaap:Assets
Current liabilitiesAt period end2014-03-31$16.21bnus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-03-31$38.21bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-14-000017. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.